XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 93 filers reported holding XENON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,202 | +74.2% | 35,210 | +96.2% | 0.01% | +100.0% |
| Q2 2023 | $690 | -99.9% | 17,946 | +12.7% | 0.01% | 0.0% |
| Q3 2022 | $574,000 | -5.1% | 15,927 | -20.0% | 0.01% | -14.3% |
| Q2 2022 | $605,000 | +282.9% | 19,902 | +92.2% | 0.01% | +600.0% |
| Q3 2021 | $158,000 | -54.5% | 10,357 | -44.5% | 0.00% | -66.7% |
| Q2 2021 | $347,000 | -7.0% | 18,654 | -10.7% | 0.00% | -25.0% |
| Q1 2021 | $373,000 | +56.7% | 20,878 | +14.6% | 0.00% | -60.0% |
| Q4 2019 | $238,000 | – | 18,220 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |